On October 29, 2015, the Centers for Medicare and Medicaid Services (CMS) released a new proposed coverage policy for hematopoietic stem cell transplant that could allow some Medicare patients with sickle cell disease, myelofibrosis, and multiple myeloma to receive the service. ASH supported the request to change the policy and is pleased to see the positive reaction, but is reviewing the proposal in more detail.